
Ian D. Dang
Examiner (ID: 17375)
| Most Active Art Unit | 1647 |
| Art Unit(s) | 1647 |
| Total Applications | 358 |
| Issued Applications | 151 |
| Pending Applications | 21 |
| Abandoned Applications | 186 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 5148771
[patent_doc_number] => 20070048831
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2007-03-01
[patent_title] => 'CYTOKINE RECEPTOR ZCYTOR17 MULTIMERS'
[patent_app_type] => utility
[patent_app_number] => 11/552637
[patent_app_country] => US
[patent_app_date] => 2006-10-25
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 12
[patent_figures_cnt] => 12
[patent_no_of_words] => 85804
[patent_no_of_claims] => 17
[patent_no_of_ind_claims] => 8
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0048/20070048831.pdf
[firstpage_image] =>[orig_patent_app_number] => 11552637
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/552637 | CYTOKINE RECEPTOR ZCYTOR17 MULTIMERS | Oct 24, 2006 | Abandoned |
Array
(
[id] => 5149470
[patent_doc_number] => 20070049530
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2007-03-01
[patent_title] => 'CYTOKINE RECEPTOR ZCYTOR17 MULTIMERS'
[patent_app_type] => utility
[patent_app_number] => 11/552653
[patent_app_country] => US
[patent_app_date] => 2006-10-25
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 12
[patent_figures_cnt] => 12
[patent_no_of_words] => 85793
[patent_no_of_claims] => 11
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0049/20070049530.pdf
[firstpage_image] =>[orig_patent_app_number] => 11552653
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/552653 | CYTOKINE RECEPTOR ZCYTOR17 MULTIMERS | Oct 24, 2006 | Abandoned |
Array
(
[id] => 5148772
[patent_doc_number] => 20070048832
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2007-03-01
[patent_title] => 'CYTOKINE RECEPTOR ZCYTOR17 MULTIMERS'
[patent_app_type] => utility
[patent_app_number] => 11/552647
[patent_app_country] => US
[patent_app_date] => 2006-10-25
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 12
[patent_figures_cnt] => 12
[patent_no_of_words] => 85808
[patent_no_of_claims] => 13
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0048/20070048832.pdf
[firstpage_image] =>[orig_patent_app_number] => 11552647
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/552647 | CYTOKINE RECEPTOR ZCYTOR17 MULTIMERS | Oct 24, 2006 | Abandoned |
Array
(
[id] => 6528733
[patent_doc_number] => 20100015146
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2010-01-21
[patent_title] => 'TREATING DIABETES USING INHIBITORS OF IL-1'
[patent_app_type] => utility
[patent_app_number] => 12/090124
[patent_app_country] => US
[patent_app_date] => 2006-10-11
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 11960
[patent_no_of_claims] => 17
[patent_no_of_ind_claims] => 7
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0015/20100015146.pdf
[firstpage_image] =>[orig_patent_app_number] => 12090124
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/090124 | TREATING DIABETES USING INHIBITORS OF IL-1 | Oct 10, 2006 | Abandoned |
Array
(
[id] => 6144463
[patent_doc_number] => 20110130329
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2011-06-02
[patent_title] => 'Glp-1 Fusion Peptides, Their Production and Use'
[patent_app_type] => utility
[patent_app_number] => 11/991562
[patent_app_country] => US
[patent_app_date] => 2006-09-22
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 23
[patent_figures_cnt] => 23
[patent_no_of_words] => 19214
[patent_no_of_claims] => 37
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0130/20110130329.pdf
[firstpage_image] =>[orig_patent_app_number] => 11991562
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/991562 | GLP-1 fusion peptides, their production and use | Sep 21, 2006 | Issued |
Array
(
[id] => 6492905
[patent_doc_number] => 20100209382
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2010-08-19
[patent_title] => 'Polyphenol Conjugates as RGD-Binding Compounds and Methods of Use'
[patent_app_type] => utility
[patent_app_number] => 11/992152
[patent_app_country] => US
[patent_app_date] => 2006-09-18
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 8
[patent_figures_cnt] => 8
[patent_no_of_words] => 6441
[patent_no_of_claims] => 34
[patent_no_of_ind_claims] => 9
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0209/20100209382.pdf
[firstpage_image] =>[orig_patent_app_number] => 11992152
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/992152 | Polyphenol Conjugates as RGD-Binding Compounds and Methods of Use | Sep 17, 2006 | Abandoned |
Array
(
[id] => 5552736
[patent_doc_number] => 20090286722
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2009-11-19
[patent_title] => 'Analogs of Gastric Inhibitory Polypeptide as a Treatment for Age Related Decreased Pancreatic Beta Cell Function'
[patent_app_type] => utility
[patent_app_number] => 11/991638
[patent_app_country] => US
[patent_app_date] => 2006-09-08
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 27
[patent_figures_cnt] => 27
[patent_no_of_words] => 21095
[patent_no_of_claims] => 40
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0286/20090286722.pdf
[firstpage_image] =>[orig_patent_app_number] => 11991638
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/991638 | Analogs of Gastric Inhibitory Polypeptide as a Treatment for Age Related Decreased Pancreatic Beta Cell Function | Sep 7, 2006 | Abandoned |
Array
(
[id] => 13669
[patent_doc_number] => 07807636
[patent_country] => US
[patent_kind] => B1
[patent_issue_date] => 2010-10-05
[patent_title] => 'Bovine P-selectin glycorpotein ligand-1'
[patent_app_type] => utility
[patent_app_number] => 11/512934
[patent_app_country] => US
[patent_app_date] => 2006-08-30
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 8
[patent_figures_cnt] => 10
[patent_no_of_words] => 9964
[patent_no_of_claims] => 13
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 19
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/807/07807636.pdf
[firstpage_image] =>[orig_patent_app_number] => 11512934
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/512934 | Bovine P-selectin glycorpotein ligand-1 | Aug 29, 2006 | Issued |
Array
(
[id] => 5148255
[patent_doc_number] => 20070048314
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2007-03-01
[patent_title] => 'Process for preparing purified drug conjugates'
[patent_app_type] => utility
[patent_app_number] => 11/503781
[patent_app_country] => US
[patent_app_date] => 2006-08-14
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 13137
[patent_no_of_claims] => 41
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0048/20070048314.pdf
[firstpage_image] =>[orig_patent_app_number] => 11503781
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/503781 | Process for preparing purified drug conjugates | Aug 13, 2006 | Issued |
Array
(
[id] => 7987583
[patent_doc_number] => 08076086
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2011-12-13
[patent_title] => 'Methods of modulating the activity of TANGO332'
[patent_app_type] => utility
[patent_app_number] => 11/499835
[patent_app_country] => US
[patent_app_date] => 2006-08-04
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 109
[patent_figures_cnt] => 109
[patent_no_of_words] => 59438
[patent_no_of_claims] => 1
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 265
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/08/076/08076086.pdf
[firstpage_image] =>[orig_patent_app_number] => 11499835
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/499835 | Methods of modulating the activity of TANGO332 | Aug 3, 2006 | Issued |
Array
(
[id] => 5194362
[patent_doc_number] => 20070082846
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2007-04-12
[patent_title] => 'Nucleotide and protein sequences of vertebrate delta genes and methods based thereon'
[patent_app_type] => utility
[patent_app_number] => 11/492497
[patent_app_country] => US
[patent_app_date] => 2006-07-24
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 40
[patent_figures_cnt] => 40
[patent_no_of_words] => 24066
[patent_no_of_claims] => 98
[patent_no_of_ind_claims] => 33
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0082/20070082846.pdf
[firstpage_image] =>[orig_patent_app_number] => 11492497
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/492497 | Nucleotide and protein sequences of vertebrate delta genes and methods based thereon | Jul 23, 2006 | Issued |
Array
(
[id] => 4644433
[patent_doc_number] => 08022038
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2011-09-20
[patent_title] => 'Composition for acceleration of type I collagen production'
[patent_app_type] => utility
[patent_app_number] => 12/088655
[patent_app_country] => US
[patent_app_date] => 2006-07-20
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 5
[patent_figures_cnt] => 10
[patent_no_of_words] => 8151
[patent_no_of_claims] => 8
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 19
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/08/022/08022038.pdf
[firstpage_image] =>[orig_patent_app_number] => 12088655
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/088655 | Composition for acceleration of type I collagen production | Jul 19, 2006 | Issued |
Array
(
[id] => 4276
[patent_doc_number] => 07816321
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2010-10-19
[patent_title] => 'Thymosin β4 derivatives and use thereof'
[patent_app_type] => utility
[patent_app_number] => 11/995817
[patent_app_country] => US
[patent_app_date] => 2006-07-14
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 6
[patent_figures_cnt] => 14
[patent_no_of_words] => 8742
[patent_no_of_claims] => 4
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 21
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/816/07816321.pdf
[firstpage_image] =>[orig_patent_app_number] => 11995817
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/995817 | Thymosin β4 derivatives and use thereof | Jul 13, 2006 | Issued |
Array
(
[id] => 6467223
[patent_doc_number] => 20100040608
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2010-02-18
[patent_title] => 'Use of HMGB1 antagonists for the treatment of inflammatory skin conditions'
[patent_app_type] => utility
[patent_app_number] => 11/988896
[patent_app_country] => US
[patent_app_date] => 2006-07-11
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 23
[patent_figures_cnt] => 23
[patent_no_of_words] => 25470
[patent_no_of_claims] => 30
[patent_no_of_ind_claims] => 13
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0040/20100040608.pdf
[firstpage_image] =>[orig_patent_app_number] => 11988896
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/988896 | Use of HMGB1 antagonists for the treatment of inflammatory skin conditions | Jul 10, 2006 | Abandoned |
Array
(
[id] => 5835341
[patent_doc_number] => 20060247172
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2006-11-02
[patent_title] => 'Methods and compositions for control of fetal growth via modulation of relaxin'
[patent_app_type] => utility
[patent_app_number] => 11/478267
[patent_app_country] => US
[patent_app_date] => 2006-06-28
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 4
[patent_figures_cnt] => 4
[patent_no_of_words] => 32409
[patent_no_of_claims] => 21
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0247/20060247172.pdf
[firstpage_image] =>[orig_patent_app_number] => 11478267
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/478267 | Methods and compositions for control of fetal growth via modulation of relaxin | Jun 27, 2006 | Abandoned |
Array
(
[id] => 5051380
[patent_doc_number] => 20070031925
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2007-02-08
[patent_title] => 'Small molecular weight TNF receptor multimeric molecule'
[patent_app_type] => utility
[patent_app_number] => 11/441858
[patent_app_country] => US
[patent_app_date] => 2006-05-26
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 5
[patent_figures_cnt] => 5
[patent_no_of_words] => 6126
[patent_no_of_claims] => 14
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0031/20070031925.pdf
[firstpage_image] =>[orig_patent_app_number] => 11441858
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/441858 | Small molecular weight TNF receptor multimeric molecule | May 25, 2006 | Abandoned |
Array
(
[id] => 5534063
[patent_doc_number] => 20090233851
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2009-09-17
[patent_title] => 'Insulin Resistance Improver'
[patent_app_type] => utility
[patent_app_number] => 11/921027
[patent_app_country] => US
[patent_app_date] => 2006-05-26
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 18
[patent_figures_cnt] => 18
[patent_no_of_words] => 11450
[patent_no_of_claims] => 21
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0233/20090233851.pdf
[firstpage_image] =>[orig_patent_app_number] => 11921027
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/921027 | Insulin Resistance Improver | May 25, 2006 | Abandoned |
Array
(
[id] => 5091669
[patent_doc_number] => 20070231308
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2007-10-04
[patent_title] => 'Glucagon-like-peptide-2 (GLP-2) analogues'
[patent_app_type] => utility
[patent_app_number] => 11/429168
[patent_app_country] => US
[patent_app_date] => 2006-05-04
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 15
[patent_figures_cnt] => 15
[patent_no_of_words] => 29448
[patent_no_of_claims] => 48
[patent_no_of_ind_claims] => 6
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0231/20070231308.pdf
[firstpage_image] =>[orig_patent_app_number] => 11429168
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/429168 | Glucagon-like-peptide-2 (GLP-2) analogues | May 3, 2006 | Issued |
Array
(
[id] => 5732246
[patent_doc_number] => 20060257363
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2006-11-16
[patent_title] => 'Treatment using an interferon'
[patent_app_type] => utility
[patent_app_number] => 11/410438
[patent_app_country] => US
[patent_app_date] => 2006-04-24
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 16
[patent_figures_cnt] => 16
[patent_no_of_words] => 16490
[patent_no_of_claims] => 3
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0257/20060257363.pdf
[firstpage_image] =>[orig_patent_app_number] => 11410438
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/410438 | Treatment using an interferon | Apr 23, 2006 | Abandoned |
| 11/353161 | Interleukin-17F antibodies and other IL-17F signaling antagonists and uses therefor | Feb 13, 2006 | Abandoned |